ZENTALIS PHARMACEUTICALS INC (ZNTL) Forecast, Price Target & Analyst Ratings

NASDAQ:ZNTL • US98943L1070

Current stock price

4.04 USD
+0.15 (+3.86%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ZENTALIS PHARMACEUTICALS INC (ZNTL).

Forecast Snapshot

Consensus Price Target

Price Target
$5.83
+ 44.27% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.49
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
77.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.83
Upside
+ 44.27%
From current price of $4.04 to mean target of $5.83, Based on 15 analyst forecasts
Low
$2.02
Median
$5.10
High
$10.50

Price Target Revisions

1 Month
19.05%
3 Months
7.56%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for ZNTL. The average price target is 5.83 USD. This implies a price increase of 44.27% is expected in the next year compared to the current price of 4.04.
The average price target has been revised upward by 7.56% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ZNTL Current Analyst RatingZNTL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

ZNTL Historical Analyst RatingsZNTL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
77.33%
ZNTL was analyzed by 15 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about ZNTL.
In the previous month the buy percentage consensus was at a similar level.
ZNTL was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-10GuggenheimMaintains Buy -> Buy
2026-03-27GuggenheimReiterate Buy -> Buy
2025-11-12Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-08-07Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-05-15WedbushReiterate Neutral -> Neutral
2025-05-15HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-28WedbushReiterate Neutral -> Neutral
2025-03-27HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-17HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-30Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-01-29HC Wainwright & Co.Maintains Buy -> Buy
2025-01-28UBSMaintains Neutral -> Neutral
2024-11-15GuggenheimMaintains Buy -> Buy
2024-11-15HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-16OppenheimerReiterate Outperform -> Outperform
2024-08-12WedbushUpgrade Underperform -> Neutral
2024-08-12HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-20UBSDowngrade Buy -> Neutral
2024-06-18OppenheimerMaintains Outperform -> Outperform
2024-06-18StifelMaintains Buy -> Buy
2024-06-18Wells FargoDowngrade Overweight -> Equal-Weight
2024-06-18Morgan StanleyDowngrade Overweight -> Equal-Weight
2024-06-18HC Wainwright & Co.Maintains Buy -> Buy
2024-05-08StifelMaintains Buy -> Buy
2024-05-08HC Wainwright & Co.Maintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.49
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
13.20%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-1.76%
EPS (3 Months)
-14.01%

Next Earnings Summary

ZNTL is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.49 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ZNTL revenue by date.ZNTL revenue by date.
67.425M
-100.00%		22.23M74.671M
235.90%		165.39M
121.49%		275.6M
66.64%		436.34M
58.32%		589.65M
35.14%		708.51M
20.16%
EBITDA
YoY % growth
ZNTL ebitda by date.ZNTL ebitda by date.
-225.86M
-9.01%		-247.552M
-9.60%		-186.169M
24.80%		-146.544M
22.50%		-178.508M
-23.73%		-167.833M
5.98%		-148.033M
11.80%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
ZNTL ebit by date.ZNTL ebit by date.
-227.29M
-9.41%		-248.941M
-9.53%		-187.458M
24.70%		-153.458M
22.64%		-157.151M
-8.37%		-158.894M
-1.11%		-156.023M
1.81%		-77.347M
50.43%		-7.862M
89.84%		97.865M
1,344.80%		180.54M
84.48%		245.88M
36.19%
Operating Margin
ZNTL operating margin by date.ZNTL operating margin by date.
N/AN/A-278.02%N/AN/A-714.77%-208.95%-46.77%-2.85%22.43%30.62%34.70%
EPS
YoY % growth
ZNTL eps by date.ZNTL eps by date.
-4.53
8.30%		-4.64
-2.43%		-2.28
50.86%		-2.02
21.05%		-1.94
-7.52%		-1.66
14.10%		-1.49
10.23%		-0.56
62.59%		-0.13
76.26%		0.38
384.62%		0.99
162.16%		1.52
53.61%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.49
13.20%		-0.48
-28.99%		-0.50
-35.33%		-0.50
0.40%		-0.32
34.95%		-0.30
36.95%		-0.27
47.03%		-0.16
68.25%
Revenue
Q2Q % growth		N/A6.059M13.811M25.826M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-38.156M
-4.04%		-39.731M
-10.19%		-41.539M
-23.14%		-44.268M
-18.38%		-42.393M
-11.11%		-38.338M
3.51%		-32.863M
20.89%		-23.674M
46.52%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ZNTL Yearly Revenue VS EstimatesZNTL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2024 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
ZNTL Yearly EPS VS EstimatesZNTL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -2 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
5.40%
EPS Next 5 Year
14.01%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
1.16%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ZENTALIS PHARMACEUTICALS INC / ZNTL Forecast FAQ

What is the average price target for ZENTALIS PHARMACEUTICALS INC (ZNTL) stock?

15 analysts have analysed ZNTL and the average price target is 5.83 USD. This implies a price increase of 44.27% is expected in the next year compared to the current price of 4.04.

What is the next earnings date for ZNTL stock?

ZENTALIS PHARMACEUTICALS INC (ZNTL) will report earnings on 2026-05-12.

What are the consensus estimates for ZNTL stock next earnings?

The consensus EPS estimate for the next earnings of ZENTALIS PHARMACEUTICALS INC (ZNTL) is -0.49 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for ZENTALIS PHARMACEUTICALS INC (ZNTL) stock?

The consensus rating for ZENTALIS PHARMACEUTICALS INC (ZNTL) is 77.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.